Modulation of experimental systemic lupus erythematosus.
Mozes
E
E
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Segal
R
R
Sthoeger
Z
Z
Dayan
M
M
Zinger
H
H
Kohn
L D
LD
Singer
D S
DS
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D013629:Tamoxifen / Q000627:therapeutic use
D018501:Antirheumatic Agents; D004965:Estrogen Antagonists; D000949:Histocompatibility Antigens Class II; D013629:Tamoxifen; D008713:Methimazole; D008727:Methotrexate